Peptides International obtains distribution rights for Intrinsic LifeSciences Diagnostic Kits

LOUISVILLE, Ky. - June 16, 2015 - PRLog -- Peptides International is pleased to announce that the company has entered into an agreement with Intrinsic Lifesciences to distribute their diagnostic hepcidin ELISA kits.  Hepcidin, an iron-attenuating hormone, is a 25 amino acid peptide containing 4 disulfide bonds.  Several important diseases such as hemochromatosis, beta-thalassemia, and anemia of chronic disease, are directly related to dysregulation of liver hepcidin production.  Peptides International is a leader in supplying hepcidin and hepcidin-related peptide products.  Intrinsic Lifesciences is a pioneer in the discovery of hepcidin and monoclonal antibodies to hepcidin, human hepcidin testing, and human IVD and pre-clinical animal model hepcidin kits.  The first of these products is the Hepcidin-Murine Compete™ ELISA Kit (https://www.pepnet.com/Products/Detail/3665/Hepcidin-Murine-Compete-sup-TM-sup-ELISA-Kit).

“The partnership we have with Intrinsic Lifesciences to distribute their hepcidin ELISA kits perfectly fits with our desire to offer superior hepcidin and hepcidin-related diagnostic products,” said Michael Pennington, Ph.D., President and CEO of Peptides International.

“This partnership with Peptides International is a natural extension of our long term collaboration with Peptides International to develop and employ the highest quality bioactive hepcidin reference materials and novel hepcidin reagents in our ELISA kits and for our CRO testing for Phase I-III clinical trials for our pharmaceutical customers“ said Mark Westerman, Ph.D., President and CEO of Intrinsic Lifesciences.

Intrinsic LifeSciences, The BioIron Company™ (ILS; intrinsiclifesciences.com), located in La Jolla, California, specializes in human hepcidin clinical testing services, pre-clinical animal model hepcidin testing, and human IVD and animal model hepcidin kit development. ILS validated the first ELISA for human serum hepcidin and provides clinical hepcidin testing services and ELISA kits to pharmaceutical customers, CROs, and clinical investigators worldwide. ILS will also begin offering CAP/CLIA certified human hepcidin testing via IntrinsicDx™beginning in Q3 2015.

Peptides International Inc. (PEPNET.COM (http://www.pepnet.com/)), headquartered in Louisville, Kentucky, specializes in manufacturing and distributing high purity, biologically active peptides, enzyme substrates and inhibitors, innovative polymers and related products, and custom peptide synthesis services to major corporations and research institutions throughout the world.